Tennessee Oncology Centennial Clinic (Sarah Cannon Research Institute)
Welcome,         Profile    Billing    Logout  
 3 Trials 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Donnellan, William
CYNK001AML01, NCT04310592: Natural Killer Cell (CYNK-001) Infusions in Adults with AML

Terminated
1
27
US
CYNK-001
Celularity Incorporated
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute, Neoplasms by Histologic Type, Neoplasms, Immunosuppressive Agents, Immunologic Factors, Physiological Effects of Drugs, Alkylating Agents, Antimetabolites, Antineoplastic, Antiviral Agents, Analgesics, Non-narcotic, Anti-infective Agents, Analgesics, Peripheral Nervous System Agents, Hematologic Diseases, Hematologic Neoplasms, Leukemia in Remission, Relapsed Adult AML, Refractory AML
01/23
04/23

Download Options